quinazolines has been researched along with Cancer of the Urethra in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for quinazolines and Cancer of the Urethra
| Article | Year |
|---|---|
Afatinib Is Active in Platinum-Refractory ERBB-Mutant Urothelial Carcinoma.
Topics: Afatinib; Antineoplastic Agents; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Mutation; Platinum; Prognosis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Treatment Outcome; Urethral Neoplasms | 2016 |